Chemours (CC) PT Lowered to $26 at RBC Capital

July 1, 2026 6:52 AM

RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $26.00 (from $29.00) while maintaining a Outperform rating.

No results found